D-0229-2018 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

Recall Details

Product Type
Drugs
Report Date
January 31, 2018
Initiation Date
January 16, 2018
Termination Date
September 14, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
393 vials

Product Description

DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/mL), 10 mL Single Use Vial, Distributed by: Sun Pharmaceutical Industries , Inc. Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway. Halol-389 350, Gujarat, India. NDC 47335-049-40

Reason for Recall

Lack Of Assurance Of Sterility

Distribution Pattern

Product was distributed nationwide in the USA

Code Information

Lot # JKS0403A Exp 02/2019